Breaking News, Collaborations & Alliances, Promotions & Moves

Kindeva, Syntegon Install First Versynta microBatch in North America

New Versynta microBatch underlines Kindeva’s injectable CDMO capabilities.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Syntegon announced the sale of its newly developed Versynta microBatch production cell to its first U.S. customer. Kindeva Drug Delivery will use Versynta microBatch to expand its suite of aseptic fill-finish contract development and manufacturing (CDMO) capabilities meeting the latest global pharmaceutical regulations and trends. Kindeva is a global CDMO that develops and manufactures products across a range of routes of administration including injectable, pulmonary, nasal, transdermal, and in...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters